rss
BMJ Case Reports 2011; doi:10.1136/bcr.06.2011.4353
  • Images in...

Adrenocorticotropic hormone independent macronodular adrenal hyperplasia

  1. Louise Wolmarans3
  1. 1Middlemore Hospital, Auckland, New Zealand
  2. 2Tauranga Hospital, Tauranga, New Zealand
  3. 3Waikato Hospital, Hamilton, New Zealand
  1. Correspondence to Dr Peter Mwamure, peter.mwamure{at}doctors.org.uk

Description

Figure 1 is of a CT scan showing bilateral macronodular adrenal glands in a patient with adrenocorticotropic hormone-independent macronodular adrenal hyperplasia (AIMAH).

Figure 1

CT scan of the adrenal glands.

AIMAH was first described in 19641.

AIMAH is often discovered as a fortuitous radiological finding, as in our patient, or during investigation for endogenous hypercortisolism. AIMAH represents less than 1% of patients with endogenous Cushing’s syndrome.

Most AIMAH patients are diagnosed in the fifth and sixth decades.

CT imaging normally shows bilateral adrenal nodules, which sometimes grow to as large as 5 cm, often with a combined adrenal weight of more than 60 g2. Although recent AIMAH data suggest that larger adrenal nodules accumulate an increased number of genomic and transcript abnormalities,3 AIMAH is a benign process that has so far not been shown to become malignant.

The secretion of cortisol in most patients with AIMAH is under the influence of hormones other than adrenocorticotropic hormone, which stimulate aberrantly expressed receptors in the adrenal glands.2 Examples include G-protein coupled receptors for glucose-dependent insulinotropic peptide, β-adrenergic receptors, vasopressin (V2, V3) receptors, serotonin (5-hydroxytryptamine) receptors and leptin receptors.

La Croix has described useful protocols for identifying various aberrant receptors as well potential medical treatment options.2 Treatment for AIMAH includes specific blockade of aberrant receptors where applicable. When specific blockade of aberrant receptors is not possible, unilateral adrenalectomy is recommended in those patients with moderate steroid hormone excess. In patients with very high levels of steroid hormone production, bilateral adrenalectomy is the treatment of choice.

Footnotes

  • Competing interests None.

  • Patient consent Not obtained.

References

Register for free content

The full text of all Editor's Choice articles and summaries of every article are free without registration

The full text of Images in ... articles are free to registered users

Only fellows can access the full text of case reports (apart from Editor's Choice) - become a fellow today, or encourage your institution to, so that together we can grow and develop this resource

Don't forget to sign up for content alerts so you keep up to date with all the case reports as they are published, and let us know what you think by commenting on the Editor's blog

Navigate This Article